AzTrials
AzTrials

StuntingIECDZNCT02234726

Improving Early Childhood Development in Zambia

A study testing Early Childhood Development Program in people with Stunting and Child Development, run by Zambia Center for Applied Health Research and Development at 2 sites in Zambia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the impact of a community-based early childhood development (ECD) program on children's physical and cognitive development. Under the program, targeted communities will be assigned a trained Child Development Agent (CDA) who will have four main tasks and responsibilities: 1)… Read more about this study

Who is it for?
Ages 6 to 12 monthsHealthy volunteers can take part
Conditions the study is for
Stunting, Child Development
What is being tested?
Early Childhood Development Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
526 participants
Where
2 sitesZambia
Study dates
Aug 2014to Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Child ages 6 to 12 months at the time of intervention launch residing in the catchment areas of the five study health facilities
  • Child's mother or main caregiver must be 15 years or older
  • Child's primary caregiver must be a female (because the participants in the caregiver groups may feel uncomfortable discussing certain issues if a man is present)

Who cannot join

  • Caregivers who are unwilling to provide informed consent
  • Families that plan to move from their health center catchment zone during the twelve month period of the study

Trial locations and contacts

2 sites in 1 country.

Zambia2 sites
  • Choma District Medical Office

    Choma, Southern Province

  • Pemba District Medical Office

    Pemba, Southern Province

Other trials in Zambia

About this study

The purpose of this study is to evaluate the impact of a community-based early childhood development (ECD) program on children's physical and cognitive development. Under the program, targeted communities will be assigned a trained Child Development Agent (CDA) who will have four main tasks and responsibilities: 1) biweekly screening and management (including referral) of acute malnutrition in children; 2) encouragement of caregivers to utilize routine care services for children; 3) screening for symptoms of acute diseases including malaria, diarrhea, and pneumonia and referral for diagnosis and treatment; and 4) organization and mentoring of biweekly caregiver meetings to discuss parenting and promote early childhood cognitive stimulation. The investigators will enroll at baseline around 600 children ages 6 - 12 months and their caregivers, and randomize them at the community-level to receive the ECD program or to remain in the control group. The study period will be one year. At end line, the investigators will collect important indicators of child physical and cognitive development to assess program impact. If the program shows both feasibility and impact, there is the potential to integrate program interventions into existing national community-based health initiatives.

Amendment: the study period has been extended for a second year. After a five month gap when no intervention was provided, biweekly (i.e., fortnightly) community-based parenting groups were restarted in intervention clusters. In the second year of the intervention, CDAs no longer visit households.

Read the detailed description

The purpose of this study is to evaluate the impact of a community-based early childhood development (ECD) program on child physical and cognitive development. Central to the ECD program is a cadre of community-based health workers called Child Development Agents (CDAs). CDAs have four main tasks and responsibilities: 1) Biweekly screening and management (including referral) of acute malnutrition in children; 2) Encouragement of caregivers to utilize routine care services for children (immunizations, growth monitoring, and vitamin A supplementation); 3) Screening for symptoms of acute diseases including malaria, diarrhea, and pneumonia and referral for diagnosis and treatment; and 4) Organization and mentoring of weekly meetings for caregivers to discuss parenting issues and promote early childhood cognitive stimulation.

Protocols for the community-based evaluation and management of children with acute malnutrition are based on the draft Zambian Community Integrated Management of Acute Malnutrition (CIMAM) guidelines. Children with complicated severe acute malnutrition (SAM) are referred to the nearest health center for evaluation and, if SAM is confirmed based on mid-upper arm circumference (MUAC), then referred to an inpatient feeding center for management. All children with moderate acute malnutrition (MAM) and uncomplicated SAM are administered an appetite test at the health center. Children who pass the appetite test are managed locally as outpatients. Children with acute infectious diseases are treated following the Ministry of Health's adaptation of the Integrated Management of Childhood Illness (IMCI) guidelines and those with complicated SAM or feeding difficulties are referred to higher level facilities (feeding centers). As part of the ECD program, clinical staff members at study health centers receive a short training to improve their adherence to IMCI and CIMAM guidelines.

One aspect of the IECDZ program that is of particular interest from a policy and evaluation perspective is the explicit focus on improving communication between CDAs and clinical staff at facilities handling undernourished children. As part of the ECD program, CDAs meet with staff at referral health centers on a regular basis, and discuss strategies to improve nutritional outcomes of children falling behind.

In addition to these regular meetings, the ECD program strengthens the linkages between CDAs and health centers with a novel mHealth intervention. When a CDA refers a child to a health center for evaluation of acute malnutrition, danger signs, or signs/symptoms suggestive of malaria, pneumonia or diarrhea, the officer-in-charge at the health center receives an short message service (SMS) and a paper referral form to make them aware of the child and their provisional diagnosis. Once the referred child has been attended to at the facility, health center staff members will then send an SMS back to the CDA to make them aware of the final diagnosis and management plan. If the health center refers the child to a feeding center, an SMS is sent to the feeding center along with a paper referral form. All text messages within the proposed system are free of charge to the end users. The mobile health (mHealth) system is meant to improve communication between health workers operating at various levels of the health system. Caregivers themselves do not receive SMS updates. Rather, CDAs will communicate all updates on the health and nutritional status of children directly to caregivers.

The primary objectives of the ECD program are to:

  1. Improve community-based screening for uncomplicated acute malnutrition and to strengthen referral to and the quality of management of malnourished children at local health centers;
  2. Conduct community-based screening and referral for management of common childhood diseases (malaria, diarrhea, and pneumonia);
  3. Strengthen the continuum of care for children with acute malnutrition and disease using an innovative mHealth intervention to link CDAs, the children that they are screening, and health centers and feeding centers; and
  4. Improve early cognitive development through community-based weekly meetings with caregivers.

The proposed evaluation will be structured around the ECD program roll out, and will employ a cluster-randomized trial design. For the purposes of the evaluation, a cluster is demarcated by the boundaries of a health zone, a geographic unit defined and used by the Zambia Ministry of Health to determine catchment populations for public health facilities. Each health zone and the children recruited from within the zone comprise a cluster for the trial. The ECD interventions will be implemented in 15 randomly selected health zones across five facilities starting in August 2014. The remaining 15 health zones in the catchments of the five study facilities will continue using current practices and will serve as controls. Within each health zone, a total of around 20 child/caregiver pairs will be recruited and enrolled in the evaluation. In total, the investigators anticipate around 300 child/caregiver pairs being enrolled in each arm of the study, for a total of 600 child/caregiver pairs.

The study sample will be randomized at the level of the health zone to either the ECD program or to the control group using stratified random sampling methods. Prior to randomization, basic demographic information will be collected on all health zones, including: distance to the study health center, total population, and number of eligible children ages 6 to 12 months. Next, zones will be stratified according to these demographic data. Finally, within strata zones will be assigned to either the ECD intervention or to the control group using a random number generator to achieve balance within strata.

Study data will be collected from four main sources: 1) a baseline interview with study caregivers; 2) an endline interview with caregivers and a child assessment; 3) IECDZ program monitoring systems, including CDA records and SMS software; and 4) semi-structured interviews with CDAs and clinic staff.

Baseline caregiver interview - Study CDAs will conduct a baseline survey of both control and intervention households which will include: a) basic demographic and socioeconomic status, b) availability of books, toys and other reading material at home, time spent by caregivers reading to the child, as well as time spent by caregivers playing with the child, c) anthropometric screening (weight, height, and MUAC), d) review of vaccinations and child health visits using child health card, e) assessment of maternal or caregiver mental well-being, f) assessment of maternal depression with the self-reporting questionnaire-20 (SRQ-20), and g) presence of other early childhood development programs in the community.

End line caregiver interview and child assessment - Twelve months after enrollment all children will be visited for a final interview and assessment. This assessment will include the questions asked at baseline as well as an assessment of child development using a standardized test-the INTERGROWTH 21st century assessment tool.

ECD program monitoring systems - Data on key process indicators will be collected from ECD program records to assess the activities of CDAs and study clinics. Important indicators include: a) volume of CDA household visits; b) volume of children identified and referred for malnutrition and/or disease; c) volume of successful referrals; and d) volume of SMS sent between CDAs and study clinics. Additional ECD program monitoring systems dedicated to the caregiver groups' cognitive stimulation are: a) frequency of caregiver groups, b) caregiver knowledge of topics covered by the curriculum, and c) measures of caregiver-child interaction quality. These data do not exist for control areas, so they will not be used to evaluate the impact of the ECD program. However, these data will provide important information that will be used to better understand any program impacts that are identified.

Interviews with CDAs and clinic staff - A series of semi-structured interviews will be conducted with CDAs and clinic staff members to assess both awareness of child nutrition and disease issues and general perceptions of the ECD program. These interviews will be conducted with all study CDAs and staff from all study facilities at three time points.

For analyses, the primary independent variable of interest is receipt of the ECD program. Assuming proper randomization, we anticipate that all factors that might potentially confound the relationships of interest are uncorrelated with receipt of the program. We will compare baseline characteristics between the two groups to assess balance. We will collect data on potential confounders to increase precision, analyze heterogeneity and, if necessary, control for any potential imbalance. Potential confounders include: maternal and paternal education, assets, income and employment, family composition and child gender. We will also control for baseline height-for-age z-score and other baseline child health measures.

Categorical variables will be compared between groups using a chi-square test, or Fisher's exact test if cell sizes are small; continuous variables using a t-test if normally distributed or non-parametric Wilcoxon rank sum tests, if non-normal. We will model our impact measures as a function of treatment and controls using a standard regression framework.

Amendment: the study period has been extended for a second year.

Being tested
Early Childhood Development Program
Keywords
child health, child development, malnutrition, stunting, community-based health services
Medical subject headings
Growth Disorders, Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Childhood Development ProgramBehavioural

    A cadre of community-based health workers, Child Development Agents (CDAs), have four main tasks and responsibilities: 1) biweekly screening and management (including referral) of acute malnutrition in children; 2) encouragement of caregivers to utilize routine care services for children; 3) screening for symptoms of acute diseases and referral for diagnosis and treatment; and 4) organization and mentoring of weekly meetings for caregivers to discuss parenting issues and promote early childhood cognitive stimulation.

    Amendment: during second year extension, CDAs are responsible for organizing and mentoring biweekly (i.e., fortnightly) caregiver meetings. They no longer conduct household visits.

Study groups in NCT02234726
Study groupRoleWhat they receive
Early Childhood Development ProgramExperimentalTreatment clusters will be assigned a trained Child Development Agent (CDA) who will have four main tasks and responsibilities: 1) biweekly screening and management (including referral) of acute malnutrition in children; 2) encouragement of caregivers to utilize routine care services for children; 3) screening for symptoms of acute diseases including malaria, diarrhea, and pneumonia and referral for diagnosis and treatment; and 4) organization and mentoring of biweekly caregiver meetings to discuss parenting and promote early childhood cognitive stimulation. Amendment: during second year extension, CDAs are responsible for organizing and mentoring biweekly (i.e., fortnightly) caregiver meetings. They no longer conduct household visits.
Receives: Behavioral: Early Childhood Development Program
ControlNo interventionChildren residing in comparison health zones will only receive baseline and end line evaluations of their health and developmental status. There will be no active intervention in the comparison areas during the course of the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stunting

    Heights of all study children will be measured. Height-for-age z-scores will be calculated using standard WHO criteria. Stunting will be defined as having a height-for-age z-score < -2. The difference in the prevalence of stunting between children in the intervention and comparison areas will be determined.

    Measured: One year starting with baseline (August-September 2014) and finishing with end line (September 2015); Amendment: also measured at year two (extension) endline

  2. Cognitive function

    Study children will be assessed at end line using the INTERGROWTH 21st century instrument. Scores will be standardized within the study sample for analysis. Scores of children in intervention health zones will be compared with children in comparison areas to determine differences.

    Amendment: at year two (extension) endline, children are assessed using the Bayley Scale for Infant and Toddler Development (BSID-III). Scores are standardized within the study sample for analysis.

    Measured: End line (after one year); Amendment: BSID-III at year two (extension) endline

Secondary outcomes (3)
  1. Measles vaccine 2nd dose

    We will collect data on whether study children have received a second dose of measles vaccine; Zambian Ministry of Health guidelines indicate that a second dose should be given to all children at age 15 months.

    Measured: End line (one year)

  2. Treatment of severe acute malnutrition (SAM)

    Caregivers will be asked to report on whether a child received treatment for SAM at a health center.

    Measured: Baseline and end line (one year)

  3. Caregiver awareness of child development

    Caregivers will be asked at baseline and end line about their child's nutritional and developmental status, and their responses will be compared to objective measures (e.g., stunting, INTERGROWTH z-score).

    Measured: Baseline and end line (one year)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2014 (estimated)
  2. Study startAug 2014
  3. Primary completionDec 2016
  4. Study completionMar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
526 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02234726
Sponsor's protocol ID
GCC 0349-03
Acronym
IECDZ
Status last verified
Jun 2017
First submitted
8 Aug 2014
Last updated
20 Jun 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Rockers PC, Zanolini A, Banda B, Chipili MM, Hughes RC, Hamer DH, Fink G. Two-year impact of community-based health screening and parenting groups on child development in Zambia: Follow-up to a cluster-randomized controlled trial. PLoS Med. 2018 Apr 24;15(4):e1002555. doi: 10.1371/journal.pmed.1002555. eCollection 2018 Apr.

    PubMed 29689045
  • Rockers PC, Fink G, Zanolini A, Banda B, Biemba G, Sullivan C, Mutembo S, Silavwe V, Hamer DH. Impact of a community-based package of interventions on child development in Zambia: a cluster-randomised controlled trial. BMJ Glob Health. 2016 Nov 22;1(3):e000104. doi: 10.1136/bmjgh-2016-000104. eCollection 2016.

    PubMed 28588962

Questions about this trial

What is this clinical trial studying?

A study testing Early Childhood Development Program in people with Stunting and Child Development, run by Zambia Center for Applied Health Research and Development at 2 sites in Zambia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Zambia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stunting (time frame: One year starting with baseline (August-September 2014) and finishing with end line (September 2015); Amendment: also measured at year two (extension) endline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02234726, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in